Validation doesn't end when the final PQ report gets signed. That's the part people sometimes forget. The IQ/OQ/PQ process proves that a piece of equipment was installed correctly, operates within spec, and performs reliably under real conditions. But it proves those things at a specific point in time, in a specific location, under specific circumstances. When something changes, the question comes up: is this equipment still validated?

We hear this question regularly: "We had our freezer temperature mapped. Doesn't that mean it's validated?" The short answer is no. Temperature mapping and IQ/OQ/PQ qualification are related but distinct activities, and confusing the two can leave your facility exposed during an audit.

As of February 2, 2026, the FDA's new Quality Management System Regulation is in effect. If you work in pharma, biotech, or blood plasma and rely on validated equipment to store high-value products, this change affects you. Here's what happened and what you should be paying attention to.

Regulatory frameworks are being rewritten. The refrigerants your systems run on are being phased out. The technicians who service your equipment are harder to find. New therapies are demanding temperatures your current infrastructure may not support. And the tools used to monitor all of it are getting smarter.

The plasma industry looks different than it did five years ago, and the trajectory suggests the next five years will bring continued evolution. Collection volumes are increasing as demand for immunoglobulin therapies grows.

The decisions that shape your expansion happen before architects or vendors ever get involved. Thorough planning doesn't guarantee a trouble-free project, but it does tend to keep things closer to budget and schedule while producing space that actually serves the operation well.

When you start looking at custom refrigeration, we’re sure your instinct is to focus on the equipment itself. What temperature can it hold? What is the capacity? What does it cost? These are all reasonable questions, but they only get you part of the way.

If you manage ULT freezers, you already know they require more attention than typical refrigeration. But understanding why can help you make better decisions about maintenance and service partnerships.

The refrigeration industry is going through a major transition right now. For decades, most systems ran on hydrofluorocarbons (HFCs). They were reliable, relatively safe to handle, and everyone understood how they worked. But their global warming potential is too high, and regulators around the world have decided they need to be phased out.

The ultra-low temperature refrigeration industry has a problem it can't ignore anymore: there aren't enough skilled technicians to do the work. The U.S. is short more than 110,000 HVACR technicians right now, and that gap is widening. The workforce is aging out, and not enough young people are coming in to replace them.

The biopharmaceutical industry doesn't stand still. Cell and gene therapies that seemed experimental five years ago are now standard treatments. Biologics pipelines have expanded dramatically. New vaccine platforms emerged and scaled faster than anyone thought possible. All of this progress has created enormous pressure on the infrastructure that makes it work—particularly cold storage.

A freezer failure can be extremely costly. For a research lab, it could be the loss of years of research. For a pharmaceutical company, it could be a multi-million-dollar batch of a new drug that is lost. These are worst-case scenarios, but they happen, and consequences can be everything from product recalls to lawsuits, brand damage, and even business closure.

Our most successful projects start with a simple conversation. You tell us your business goals, what you need to store, and your plans for growth.

In specialized industries like pharmaceuticals, biotech, and blood banking, a freezer does more than just keep things cold.

For industries like pharmaceuticals or biotech, "cold storage" means much more than a standard freezer. When products are worth millions and regulations are strict, off-the-shelf solutions don't cut it. The right approach involves carefully designed spaces, built by experts who understand how temperature, humidity, workflow, and regulations all fit together.

A major change is coming to the world of industrial refrigeration, and the clock is ticking. A federal regulation called the American Innovation and Manufacturing (AIM) Act is phasing out a common class of refrigerants known as hydrofluorocarbons (HFCs).

In regulated industries like pharmaceuticals and biotech, the standard for critical equipment is extremely high. For any piece of equipment that can impact product quality or patient safety—especially critical systems like ultra-low temperature (ULT) freezers—you must have objective, documented proof that it works exactly as intended, every single time. This rigorous process of proof is known as validation, and it is a cornerstone of Good Manufacturing Practice (GMP).

In any facility with temperature-controlled spaces, the heating, ventilation, air conditioning, and refrigeration (HVAC/R) systems are all connected. Many businesses juggle multiple vendors for these systems. While common, this approach can lead to hidden costs, wasted time, and serious operational risks. Working with a single, expert partner for all your HVAC/R needs can solve these problems and offer clear benefits.

The various levels of temperature—4∘C, −20∘C, −80∘C—can seem arbitrary. It's possible to conceptualize cold storage as a city with different neighborhoods, and each neighborhood has its purpose.

Storing human plasma is one of the most strictly regulated parts of the cold chain. Governed by rules from the FDA and AABB, preserving these life-saving products requires a precise and verifiable environment. For blood banks, hospitals, and pharmaceutical companies, compliance is a complete system where the storage environment and the data that proves it is as important as the plasma itself.